| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.058 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.094 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.028 | 0.6 |